|Location:||EMBL-EBI & Wellcome Trust Sanger Institute, Hinxton, near Cambridge, UK|
|Contract Duration:||3 years|
|Closing Date:||21 July 2017|
EMBL-EBI and Wellcome Trust Sanger Institute share the Wellcome Genome Campus. This proximity fosters close collaborations and contributes to an international and vibrant campus environment. Researchers are supported by easy access to scientific expertise, well-equipped facilities and an active seminar programme.
The EMBL-EBI–Sanger Postdoctoral (ESPOD) Programme builds on the strong collaborative relationship between the two institutes, offering projects which combine experimental (wet lab) and computational approaches.
Projects may be selected from pre-defined areas or proposed by the applicant. In the case of self-defined projects, the area of work must have been agreed with both EMBL-EBI and Sanger-based group leaders. Two postdoctoral fellowships will be awarded in 2017, to start as soon as possible after October 2017 but within 12 months of the fellowship being awarded.
For full information on the ESPOD fellowships pleaseclick here
Project 5: Exploiting cellular CRISPR-Cas9 and chemogenomics platforms for drug discovery (Andrew Leach and Mathew Garnett)
For full on this project please click here
Applications should consist of the following:
1. A cover letter specifying the project you are applying for (see the list on this page);
2. Your curriculum vitae;
3. Two recent letters of reference.
The deadline for submission of the online application and self-proposed projects is Friday, 21 July 2017 (23:00 BST)
The initial contract is for a period of 3 years with the possibility of a fixed-term extension.
We welcome applications irrespective of gender and appointment will be based on merit alone. Applications are welcome from all nationalities - visa information will be discussed in more depth with applicants selected for interview.